Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential.

Balciunaite G, Ceredig R, Massa S, Rolink AG.

Eur J Immunol. 2005 Jul;35(7):2019-30.

2.

Contingent gene regulatory networks and B cell fate specification.

Singh H, Medina KL, Pongubala JM.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):4949-53. Review.

3.

Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Tagoh H, Schebesta A, Lefevre P, Wilson N, Hume D, Busslinger M, Bonifer C.

EMBO J. 2004 Oct 27;23(21):4275-85.

4.

Assembling a gene regulatory network for specification of the B cell fate.

Medina KL, Pongubala JM, Reddy KL, Lancki DW, Dekoter R, Kieslinger M, Grosschedl R, Singh H.

Dev Cell. 2004 Oct;7(4):607-17.

5.

Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription.

Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL, Ikawa T, Murre C, Singh H, Hardy RR, Hagman J.

Nat Immunol. 2004 Oct;5(10):1069-77.

PMID:
15361869
6.

Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions.

Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC.

J Exp Med. 2004 Aug 16;200(4):469-79.

7.

Transcriptional control of early B cell development.

Busslinger M.

Annu Rev Immunol. 2004;22:55-79. Review.

PMID:
15032574
9.

Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.

Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H, Simon MC.

Nat Immunol. 2003 Oct;4(10):1029-36.

PMID:
12958595
10.

Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential.

Martin CH, Aifantis I, Scimone ML, von Andrian UH, Reizis B, von Boehmer H, Gounari F.

Nat Immunol. 2003 Sep;4(9):866-73.

PMID:
12925850
11.

B-cell commitment: deciding on the players.

Hardy RR.

Curr Opin Immunol. 2003 Apr;15(2):158-65. Review.

PMID:
12633665
12.

Biology of hematopoietic stem cells and progenitors: implications for clinical application.

Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, Shizuru JA, Weissman IL.

Annu Rev Immunol. 2003;21:759-806. Review.

PMID:
12615892
13.

Thymopoiesis independent of common lymphoid progenitors.

Allman D, Sambandam A, Kim S, Miller JP, Pagan A, Well D, Meraz A, Bhandoola A.

Nat Immunol. 2003 Feb;4(2):168-74.

PMID:
12514733
14.

Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.

Souabni A, Cobaleda C, Schebesta M, Busslinger M.

Immunity. 2002 Dec;17(6):781-93.

15.

Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene.

Schebesta M, Pfeffer PL, Busslinger M.

Immunity. 2002 Oct;17(4):473-85.

16.

The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7.

Miller JP, Izon D, DeMuth W, Gerstein R, Bhandoola A, Allman D.

J Exp Med. 2002 Sep 2;196(5):705-11.

17.

Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow.

Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW.

Immunity. 2002 Aug;17(2):117-30.

18.
19.

Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen.

Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW.

Nat Immunol. 2001 Aug;2(8):718-24.

PMID:
11477408
20.
Items per page

Supplemental Content

Support Center